Coagulation factor IX compositions and methods of making and using same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9062299
SERIAL NO

13392511

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compositions comprising factor DC coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of coagulation factor-related diseases, disorders, and conditions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AMUNIX PHARMACEUTICALS INC2 TOWER PLACE #1100 SOUTH SAN FRANCISCO CA 94080-1826

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Geething, Nathan C Santa Clara, US 14 578
Schellenberger, Volker Palo Alto, US 137 3339
Silverman, Joshua Sunnyvale, US 61 1372
Spink, Benjamin San Carlos, US 39 893
Stemmer, Willem P Los Gatos, US 45 1755
To, Wayne Fremont, US 33 619
Wang, Chia-wei Milpitas, US 156 2513

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 23, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00